
Anthony Chambers
Principal
Relevant Areas of Expertise
Mergers & Acquisitions
Private Equity
Digital & IT Strategy
Complex Program Management
Healthcare & Life Sciences
Education
B.A. from DePaul University
Mr. Chambers is a principal with Liberty Advisor Group and has over 25 years of technology and management consulting experience focused on leading transformational programs at Fortune 500 companies, aligning technology, people, and systems with corporate mission, and brokering communication between business and technology.
Throughout his career, Anthony has been involved with large scale business and IT transformations where he has guided firms through operational, organizational, and technological change. Anthony has experience with portfolio framework creation, IT strategy analysis & development, application rationalization, and large program management (development, rescue, multi-location, multi-country).
Prior to Liberty, Anthony spent his career working primarily on M&A transactions where he was involved in all aspects of the deal lifecycle from due diligence through post merger integration. He has managed all aspects of solution design and development across a number of different industries including some of the world’s largest biopharmaceutical companies and consumer packaged goods.
Anthony’s diverse experience allows him to help clients apply the right technology to the right situation while keeping business priorities at the core of the initiative. He enjoys working with all facets of a business on complex problems where technology can provide differentiated value.
Recent insights:
See More Insights
Recent insights:
The Inflation Reduction Act and its Impact on Life Science Companies
The Inflation Reduction Act (IRA) went into effect on October 1, 2021. Its aim is to reduce inflation and support controlling the cost of
Key Elements to Writing a Transition Service Agreement
A Transition Service Agreement (TSA) is an important piece of the merger and acquisition process. Setting up an effective TSA is a complex, time-consuming
Sell-Side Due Diligence: Why is it Important in BioPharma Companies?
Generally, many companies, including those in the biopharmaceutical industry, are becoming more innovative through acquisitions and partnerships. The past few years have seen many
View More Insights
Learn More About Our People
With Our Deep Experience, Guaranteed Outcomes, and Tailored Approach, We Help Turn Our Clients' Ambitions Into Reality.
What Are Your Ambitions?